Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
40.7M
-
Shares change
-
-2.77M
-
Total reported value, excl. options
-
$1.37B
-
Value change
-
-$219M
-
Put/Call ratio
-
2.77
-
Number of buys
-
115
-
Number of sells
-
-78
-
Price
-
$33.73
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2016
238 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q2 2016.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.7M shares
of 44.9M outstanding shares and own 90.81% of the company stock.
Largest 10 shareholders include FMR LLC (5.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.43M shares), VANGUARD GROUP INC (2.59M shares), GILDER GAGNON HOWE & CO LLC (2.03M shares), BlackRock Fund Advisors (1.59M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.33M shares), STATE STREET CORP (1.2M shares), Clearbridge Investments, LLC (1.09M shares), DARUMA CAPITAL MANAGEMENT LLC (1.08M shares), and BlackRock Institutional Trust Company, N.A. (904K shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.